Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Góra-Tybor J, Gołos A, Mikulski D, Helbig G, Sacha T, Lewandowski K, Niesiobędzka-Krężel J, Bieniaszewska M, Wysogląd H, Grzybowska-Izydorczyk O, Seferyńska I, Sobas M, Czyżewska M, Michalska A, Sawicki W, Mazur M, Hus M, Bodzenta E, Olszewska-Szopa M, Włodarczyk M, Patkowska E, Świstek W, Jamroziak K. Góra-Tybor J, et al. Among authors: wlodarczyk m. Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):e19-e26. doi: 10.1016/j.clml.2022.10.002. Epub 2022 Oct 22. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36396583
Multiple tyrosine kinase inhibitors before allogeneic stem cell transplantation for chronic myeloid leukemia: toxicity and efficacy in a single-center experience.
Helbig G, Duda K, Krzemień H, Włodarczyk M, Kata D, Wieczorkiewicz-Kabut A. Helbig G, et al. Among authors: wlodarczyk m. Pol Arch Intern Med. 2020 Jun 25;130(6):553-556. doi: 10.20452/pamw.15351. Epub 2020 May 11. Pol Arch Intern Med. 2020. PMID: 32388967 Free article. No abstract available.
The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis.
Helbig G, Koclęga A, Gaweł WB, Włodarczyk M, Rodzaj M, Łabędź A, Hus I, Raźny M. Helbig G, et al. Among authors: wlodarczyk m. Indian J Hematol Blood Transfus. 2020 Oct;36(4):661-666. doi: 10.1007/s12288-020-01279-8. Epub 2020 Apr 15. Indian J Hematol Blood Transfus. 2020. PMID: 33093752 Free PMC article.
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Apr 17:e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 38629312
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Reynolds HR, Cyr DD, Merz CNB, Shaw LJ, Chaitman BR, Boden WE, Alexander KP, Rosenberg YD, Bangalore S, Stone GW, Held C, Spertus J, Goetschalckx K, Bockeria O, Newman JD, Berger JS, Elghamaz A, Lopes RD, Min JK, Berman DS, Picard MH, Kwong RY, Harrington RA, Thomas B, O'Brien SM, Maron DJ, Hochman JS; ISCHEMIA Research Group *. Reynolds HR, et al. J Am Heart Assoc. 2024 Mar 5;13(5):e029850. doi: 10.1161/JAHA.122.029850. Epub 2024 Feb 27. J Am Heart Assoc. 2024. PMID: 38410945 Free PMC article. Clinical Trial.
247 results